INTERDICT BIO, INC.

Software as a service (SAAS) computational platform for use in the development of pharmaceuticals by enabling analysis, predictions, and reporting using an annotated searchable database of protein sequences, ribosome profiling readouts, chemical matter, and biophysical assay endpoints to facilitate research into small molecules for inhibiting the translation of disease-causing cellular proteins, for use in the treatment of cancers, neurological diseases, and other diseases

research and development of pharmaceuticals, namely, research and development of pharmaceuticals using an annotated searchable database of protein sequence information to facilitate research into small molecules for inhibiting the translation of disease-causing cellular proteins, for use in the treatment of cancers, neurological diseases, and other diseases

pharmaceutical preparations comprising small molecules for inhibiting the translation of disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders; pharmaceutical products development of new small molecules for inhibiting the translation of disease-causing cellular proteins for treatment in the field of oncology, immunology, inflammatory diseases, and central nervous system disorders

Pharmaceutical preparations for the prevention and treatment of cancer, immunological disease, rare genetic diseases, and neurodegenerative diseases; "BIO"; Medical and scientific research, namely, research in the fields of oncology, immunological disease, rare genetic diseases, and neurodegenerative diseases; medical and pharmacological research services for drug discovery